Partial liquid ventilation with FC-77 suppresses the release of lipid mediators in rat acute lung injury model

Critical Care Medicine

Volumn 32, Issue 10, 2004, Pages 2085-2089

  Hirayama, Yoh ^a   Hirasawa, Hiroyuki ^a   Oda, Shigeto ^a   Shiga, Hidetoshi ^a   Matsuda, Kenichi ^a   Ueno, Hirokazu ^a   Nakamura, Masataka ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Acute lung injury; Acute respiratory distress syndrome; Anti inflammatory effect; Inflammation; Lipid mediators; Partial liquid ventilation; Perfluorocarbon

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; DIBROMOPERFLUROROHEXANE; FC 77; FLUOROCARBON; HYDROCHLORIC ACID; LEUKOTRIENE B4; PERFLUOROOCTYL BROMIDE; THROMBOXANE A2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; DRUG MECHANISM; HEMODYNAMICS; LIQUID VENTILATION; LUNG HOMOGENATE; LUNG INJURY; MALE; NONHUMAN; OXYGENATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY DISTRESS; TRACHEOSTOMY;

6-KETOPROSTAGLANDIN F1 ALPHA; ANIMALS; ARACHIDONIC ACIDS; FLUOROCARBONS; HYDROCHLORIC ACID; INFLAMMATION MEDIATORS; LEUKOTRIENE B4; LIQUID VENTILATION; MALE; MODELS, ANIMAL; RATS; RATS, SPRAGUE-DAWLEY; RESPIRATORY DISTRESS SYNDROME, ADULT; THROMBOXANE A2;

EID: 5644278736     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000142576.59654.BC     Document Type: Article

References (35)

1. Clark LC Jr, Gollan F: Survival of mammals breathing organic liquid equilibrated with oxygen at atmospheric pressure. Science 1966; 152:1755-1756
2. Weers JG: A physiochemical evaluation of perfluorochemicals for oxygen transport applications. J Fluorine Chem 1993; 64:73-93
3. Greenspan JS, Wolfson MR, Shaffer TH: Liquid ventilation. Semin Perinatol 2000; 24: 396-405
4. Kaisers U, Kelly KP, Busch T: Liquid ventilation. Br J Anaesth 2003; 91:143-151
5. Hirschl RB, Tooly R, Parent A, et al: Evaluation of gas exchange, pulmonary compliance, and lung injury during total and partial liquid ventilation in the acute respiratory distress syndrome. Crit Care Med 1996; 24: 1001-1008
6. Foust R III, Tran NN, Cox C, et al: Liquid assisted ventilation: An alternative ventilatory strategy for acute meconium aspiration injury. Pediatr Pulmonol 1996; 21:316-322
7. Bulger EM, Maier RV: Lipid mediators in the pathophysiology of critical illness. Crit Care Med 2000; 28:27-36
8. Amat M, Barcons M, Mancebo J, et al: Evolution of leukotriene B4, peptide leukotrienes, and interleukin-8 plasma concentration in patients at risk of acute respiratory distress syndrome and with acute respiratory distress syndrome: Mortality prognostic study. Crit Care Med 2000; 28:57-62
9. Stephenson AH, Lonigro AJ, Hyers TM, et al: Increased concentrations of leukotrienes in bronchoalveolar lavage fluid of patients with ARDS or at risk for ARDS. Am Rev Respir Dis 1988; 138:714-719
10. Suchner U, Katz DP, Furst P, et al: Impact of sepsis, lung injury, and the role of lipid infusion on circulating prostacyclin and thromboxane A2. Intensive Care Med 2002; 28:122-129
11. Voelkel NF, Stenmark KR, Westcott JY, et al: Lung eicosanoid metabolism. Clin Chest Med 1989; 10:95-105
12. Turner CR, Lackey MN, Quinlan MF, et al: Therapeutic intervention in a rat model of adult respiratory distress syndrome. Circ Shock 1991; 34:263-269
13. Kawamae K, Pristine G, Chiumello D, et al: Partial liquid ventilation decreases serum tumor necrosis factor-α concentrations in a rat acid aspiration lung injury model. Crit Care Med 2000; 28:479-483
14. Gaeber BG, Hebert PC, Yelle JD, et al: Adult respiratory distress syndrome: A systemic overview of incidence and risk factors. Crit Care Med 1996; 24:687-695
15. Rabinovici R, Vernick J, Hillegas L, et al: Hypertonic saline treatment of acid aspiration induced lung injury. J Surg Res 1996; 60:176-180
16. Matsuda K, Sawada S, Bartlett RH, et al: Effect of ventilatory variables on gas exchange and hemodynamics during total liquid ventilation in a rat model. Crit Care Med 2003; 31:2034-2040
17. Houmes RJM, Verbrugge SJC, Hendrik ER, et al: Hemodynamic effects of partial liquid ventilation with perfluorocarbon in acute lung injury. Intensive Care Med 1995; 21: 966-972
18. Davidson A, Heckman JL, Donner RM, et al: Cardiopulmonary interaction during partial liquid ventilation in surfactant treated preterm lambs. Eur J Pediatr 1998; 157: 138-145
19. Hirschl RB, Tooley R, Kelly DR, et al: Improvement of gas exchange, pulmonary function, and lung injury with partial liquid ventilation: A study model in a setting of severe respiratory failure. Chest 1995; 108:500-508
20. Nesti FD, Fuhrman BP, Steinhorn DM, et al: Perfluorocarbon-associated gas exchange in gastric aspiration. Crit Care Med 1994; 22: 1445-1452
21. Fuhrman BP, Paczan PR, DeFrancisis M: Perfluorocarbon-associated gas exchange. Crit Care Med 1991; 19:712-722
22. Curtis SE, Peek JT, Kelly DR: Partial liquid breathing with perflubron improves arterial oxygenation in acute canine lung injury. J Appl Physiol 1993; 75:2696-2702
23. Shaffer TH, Lowe CA, Bhutani VK, et al: liquid ventilation: Effects on pulmonary function in distressed meconium-stained lambs. Pediatr Res 1984; 18:47-52
24. Tutuncu A, Faithfull NS, Lachman B: Intratracheal perfluorocarbon administration combined with mechanical ventilation in experimental respiratory distress syndrome: Dose-dependent improvement of gas exchange. Crit Care Med 1993; 21:962-969
25. Colton DM, Till GO, Johnson KJ, et al: Neutrophil accumulation is reduced during partial liquid ventilation. Crit Care Med 1998; 26:1716-1724
26. Croce MA, Fabian TC, Patton JH, et al: Partial liquid ventilation decreases the inflammatory response in the alveolar environment of trauma patients. J Trauma 1998; 45:273-282
27. Thomassen MJ, Buhrow LT, Wiedemann HP: Perflubron decreases inflammatory cytokine production by human alveolar macrophages. Crit Care Med 1997; 25:2045-2047
28. Gauger PG, Pranikoff T, Schreiner RJ, et al: Initial experience with partial liquid ventilation in pediatric patients with the acute respiratory distress syndrome. Crit Care Med 1996; 24:16-22
29. Baba A, Kim YK, Zhang H, et al: Perfluorocarbon blocks tumor necrosis factor-α-induced interleukin-8 release from alveolar epithelial cells in vitro. Crit Care Med 2000; 28:1113-1118
30. Obraztsov W, Neslund GG, Kornbrust ES, et al: In vitro cellular effects of perfluorochemicals correlate with their lipid solubility. Am J Physiol Lung Cell Mol Physiol 2000; 278:1018-1024
31. Haeberle HA, Nesti F, Dieterich HJ, et al: Perflubron reduces lung inflammation in respiratory syncytial virus infection by inhibiting chemokine expression and nuclear factor-κB activation. Am J Respir Crit Care Med 2001; 165:1433-1438
32. Fernandez R, Sarma V, Younkin E, et al: Exposure to perflubron is associated with decreased Syk phosphorylation in human neutrophils. J Appl Physiol 2001; 91: 1941-1947
33. Paterson NA: Influence of hypoxia on histamine and leukotriene release from dispersed porcine lung cells. J Appl Physiol 1986; 61: 1790-1795
34. Nader ND, Knight PR, Davidson BA, et al: Systemic perfluorocarbons suppress the acute lung inflammation after gastric acid aspiration in rats. Anesth Analg 2000; 90: 356-361
35. Shashikant MP, Badellino MM, Cooper B, et al: Physicochemical properties of perfluorochemical liquids influence ventilatory requirements, pulmonary mechanics, and microvascular permeability during partial liquid ventilation following intestinal ischemia/reperfusion injury. Crit Care Med 2002; 30:2300-2305